The corticosteroids market was valued at USD 4.71 billion in 2023 and is projected to reach USD 6.91 billion by 2033, growing at a 4.2% CAGR.
Rheumatology led with 35% market share in 2023, while dermatology is the fastest-growing segment, boasting a 5.1% CAGR. Topical corticosteroids dominated the market, holding 49% of the share.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5111
The Forum of International Respiratory Societies estimates that over 4.5 million lives have been lost due to the ongoing pandemic, with respiratory issues being the primary cause. During this crisis, corticosteroids have played a crucial role in treating respiratory diseases.
Corticosteroids are steroid hormones naturally produced by the adrenal cortex, located on top of each kidney. These hormones regulate essential processes such as metabolism, immune response, and electrolyte balance. They are categorized into two main types:
In medicine, synthetic corticosteroids are widely used for their anti-inflammatory and immunosuppressive properties. Available as oral tablets, topical creams, inhalers, and injections, they are prescribed to manage a variety of conditions, including autoimmune disorders, allergies, asthma, inflammatory joint diseases, and skin conditions.
Healthcare providers carefully monitor corticosteroid use to minimize potential side effects such as bone loss, immune suppression, and metabolic disturbances. Treatment plans are tailored to ensure the benefits outweigh the risks, with dosages adjusted based on individual needs.
The rising prevalence of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) has driven up demand for inhaled corticosteroids as part of their treatment. Additionally, corticosteroids play a role in cancer care, helping manage chemotherapy side effects. As cancer treatments evolve, the demand for supportive medications like corticosteroids is expected to grow.
With their versatile applications and significant role in managing various health conditions, corticosteroids remain a cornerstone in modern medical treatment.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/corticosteroids-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5111
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The medical imaging market is witnessing rapid expansion worldwide, and Europe is emerging as a key contributor to this global… Read More
The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada… Read More
The surgical sutures market in the United States is showing steady and promising growth, and here’s why! 👇 👵👴 An… Read More
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More